CompletedPhase 3

Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC

Egypt150 participantsStarted 2016-03

Plain-language summary

The study will recruit 150 patients with HCV related HCC ,after HCC treatment the patients will undergo treatment with different regimens of DAAs.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-70 years old * Confirmed HCV viremia by PCR * CHILD Pugh "A" or "B7,B8" * Confirmed HCC either by laboratory ,imaging or histopathological criteria * Underwent or candidate for curative intervention for HCC (BCLC stage 0 ,A) * Willing to be treated for HCV and signing informed consent Exclusion Criteria: * Patients below 18 or above 70 years old * patients with advanced liver condition "CHILD score ≥ B9" * Patients with advanced HCC status (BCLC≥ B) * Patients with combined HBV ,HIV infection

What they're measuring

Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment

Timeframe: 12 weeks after the last dose of study drugs

Trial details

NCT IDNCT02771405

SponsorNational Hepatology & Tropical Medicine Research Institute

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2017-12

View on ClinicalTrials.gov More Hepatitis C, Chronic trials